Novo Nordisk's brand name for semaglutide approved for type 2 diabetes, taken as a weekly injection. It contains the same active ingredient as Wegovy (the brand approved for weight management): same molecule, different label. Because of its fame, "Ozempic" is often used loosely to mean any GLP-1, and it's frequently prescribed off-label for weight loss.
Related terms: Semaglutide · Wegovy · Mounjaro · Off-label prescribing